Literature DB >> 15161572

Extended and saturation needle biopsy for the diagnosis of prostate cancer.

Kristin L Chrouser1, Michael M Lieber.   

Abstract

The diagnosis of prostate cancer hinges on the use of systematic ultrasound-guided transrectal needle biopsy. The choice of technique is important, especially for patients with a history of a negative biopsy. Saturation biopsy can be considered for patients at risk of cancer who are willing to accept the side effects and who understand that clinically insignificant cancers can be detected. For patients with previous negative sextant biopsies, expanding the zones sampled and increasing the number of biopsy cores can help detect significant cancers while they are still confined. However, as extended biopsy becomes more commonly performed for initial diagnosis, there likely will be less need for saturation biopsy protocols.

Entities:  

Mesh:

Year:  2004        PMID: 15161572     DOI: 10.1007/s11934-004-0041-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  41 in total

1.  Prostate biopsy: how many cores are enough?

Authors:  Joseph C Presti
Journal:  Urol Oncol       Date:  2003 Mar-Apr       Impact factor: 3.498

2.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

Authors:  C S Stewart; B C Leibovich; A L Weaver; M M Lieber
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

3.  Critical evaluation of the current indications for transition zone biopsies.

Authors:  I J Liu; M Macy; Y H Lai; M K Terris
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

4.  Prostate cancer detection: relationship to prostate size.

Authors:  M E Chen; P Troncoso; D Johnston; K Tang; R J Babaian
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

5.  Prostate biopsy protocols: 3D visualization-based evaluation and clinical correlation.

Authors:  J Zeng; J Bauer; W Zhang; I Sesterhenn; R Connelly; J Lynch; J Moul; S K Mun
Journal:  Comput Aided Surg       Date:  2001

6.  Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.

Authors:  P G Borboroglu; S W Comer; R H Riffenburgh; C L Amling
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

7.  Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.

Authors:  J I Epstein; P C Walsh; J Sauvageot; H B Carter
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

Review 8.  Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers.

Authors:  S Jain; A G Bhojwani; J K Mellon
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

Review 9.  Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature.

Authors:  L V Rodríguez; M K Terris
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

10.  Differences in biopsy features between prostate cancers located in the transition and peripheral zone.

Authors:  H Augustin; A Erbersdobler; M Graefen; T Jaekel; A Haese; H Huland; P G Hammerer
Journal:  BJU Int       Date:  2003-04       Impact factor: 5.588

View more
  12 in total

1.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

Review 2.  Urologic imaging for localized prostate cancer in 2007.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2007-03-21       Impact factor: 4.226

3.  [Innovative approaches in prostate cancer ultrasound].

Authors:  T Loch
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

4.  Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies.

Authors:  Bjoern Grabski; Leif Baeurle; Annemie Loch; Bjoern Wefer; Udo Paul; Tillmann Loch
Journal:  World J Urol       Date:  2011-06-21       Impact factor: 4.226

5.  Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions.

Authors:  Tillmann Loch; Ursula Eppelmann; Jan Lehmann; Bernd Wullich; Annemie Loch; Michael Stöckle
Journal:  World J Urol       Date:  2004-12-01       Impact factor: 4.226

6.  [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer].

Authors:  T Loch
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

Review 7.  Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Authors:  Marc A Bjurlin; H Ballentine Carter; Paul Schellhammer; Michael S Cookson; Leonard G Gomella; Dean Troyer; Thomas M Wheeler; Steven Schlossberg; David F Penson; Samir S Taneja
Journal:  J Urol       Date:  2013-02-26       Impact factor: 7.450

8.  Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2007-08-11       Impact factor: 4.226

9.  H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples.

Authors:  Katarina Stenman; Pär Stattin; Hans Stenlund; Katrine Riklund; Gerhard Gröbner; Anders Bergh
Journal:  Biomark Insights       Date:  2011-03-14

10.  Supervised regularized canonical correlation analysis: integrating histologic and proteomic measurements for predicting biochemical recurrence following prostate surgery.

Authors:  Abhishek Golugula; George Lee; Stephen R Master; Michael D Feldman; John E Tomaszewski; David W Speicher; Anant Madabhushi
Journal:  BMC Bioinformatics       Date:  2011-12-19       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.